Krakow – Polish Selvita S.A., which offers preclinical drug development services to pharma companies, has been ranked as the No. 1 “Rising Star” of this year’s Fast50 contest. In the programme, analysts from Deloitte Technology identify the world’s fastest-growing technology companies. Selvita was the only biotechnology company in Central Europe that ranked. With a 2,623% rise in revenues over the past three years, the company beat a long list of other high-tech companies. Most recently, Selvita announced a collaboration with German Evestra GmbH for the delivery of a series of drug metabolism, pharmacokinetic (DMPK) genotoxicity and physicochemical in vitro and in vivo studies.